propranolol has been researched along with nitrophenols in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (16.67) | 18.7374 |
1990's | 6 (50.00) | 18.2507 |
2000's | 2 (16.67) | 29.6817 |
2010's | 2 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Shwed, JA; Walle, T; Walle, UK | 1 |
Carrara, MC; Jori, A | 1 |
Razzaboni, G; Setti, L; Vitolo, A | 1 |
Asano, M; Shibasaki, K; Takenaka, T; Uchida, W | 1 |
Kasuya, Y; Masuda, Y; Sakai, T; Shigenobu, K; Shudo, C; Tanaka, S | 1 |
Horita, A; Imai, T; Matsukane, H; Otagiri, M; Yoshigae, Y | 1 |
Angus, PW; Choo, EF; Morgan, DJ | 1 |
Ahlskog, JE | 1 |
Chiba, K; Hosokawa, M; Imai, T; Otagiri, M; Yoshigae, Y | 1 |
Hashimoto, M; Imai, T; Masaki, K | 1 |
Imai, T; Ninomiya, S; Ohura, K; Sakamoto, H | 1 |
Bielejewska, A; Bylina, A; Duszczyk, K; Fiałkowski, M; Hołyst, R | 1 |
1 review(s) available for propranolol and nitrophenols
Article | Year |
---|---|
Medical treatment of later-stage motor problems of Parkinson disease.
Topics: Amantadine; Antiparkinson Agents; Benzophenones; Carbidopa; Catechol O-Methyltransferase Inhibitors; Catechols; Cholinergic Antagonists; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Combinations; Dyskinesia, Drug-Induced; Enzyme Inhibitors; Humans; Levodopa; Nitriles; Nitrophenols; Parkinson Disease, Secondary; Propranolol; Randomized Controlled Trials as Topic; Selegiline; Tolcapone | 1999 |
11 other study(ies) available for propranolol and nitrophenols
Article | Year |
---|---|
Hep G2 cell line as a human model for sulphate conjugation of drugs.
Topics: Arylsulfotransferase; Carcinoma, Hepatocellular; Dopamine; Humans; Liver; Liver Neoplasms; Nitrophenols; Propranolol; Sulfates; Temperature; Terbutaline; Tumor Cells, Cultured | 1992 |
On the mechanism of the hyperglycaemic effect of chlorpromazine.
Topics: Animals; Blood Glucose; Chlorpromazine; Drug Synergism; Epinephrine; Ethanolamines; Hyperglycemia; Nitrophenols; Propranolol; Rats; Sulfonamides | 1966 |
[Cardiac action of beta-blocking agents. IV. Comparison of the capacity of propranolol and of L-(4-nitrophenyl)-2-isopropyl-amino-ethanol to prevent the electrocardiographic effects of intravenous injection of pitressin in rats].
Topics: Animals; Heart; Nitrophenols; Propranolol; Rats; Resorcinols; Sympatholytics; Vasopressins | 1968 |
Antianginal effects of YM-16151-4 in various experimental angina models.
Topics: 4-Aminopyridine; Amifampridine; Angina Pectoris; Animals; Arginine Vasopressin; Atrioventricular Node; Calcium Channel Blockers; Coronary Circulation; Coronary Vasospasm; Dihydropyridines; Dogs; Electrocardiography; Female; Heart Conduction System; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nifedipine; Nitrophenols; Oxygen Consumption; Potassium Channels; Propranolol | 1993 |
Effects of long-term oral administration of NZ-105, a novel calcium antagonist, with or without propranolol in spontaneously hypertensive rats.
Topics: Administration, Oral; Aldosterone; Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Dose-Response Relationship, Drug; Heart; Heart Rate; Hypertension; Kidney; Liver; Male; Nitrophenols; Organ Size; Organophosphorus Compounds; Propranolol; Rats; Rats, Inbred SHR; Renin; Time Factors | 1993 |
Species differences in stereoselective hydrolase activity in intestinal mucosa.
Topics: Aged; Animals; Caco-2 Cells; Cytosol; Dogs; Esters; Humans; Hydrolases; Intestinal Mucosa; Male; Microsomes; Middle Aged; Nitrophenols; Prodrugs; Propranolol; Rats; Rats, Wistar; Species Specificity; Stereoisomerism | 1998 |
Effect of cirrhosis on sulphation by the isolated perfused rat liver.
Topics: Animals; Liver; Liver Cirrhosis, Experimental; Male; Nitrophenols; Oxidation-Reduction; Perfusion; Propranolol; Rats; Rats, Wistar | 1999 |
Evidence for the involvement of a pulmonary first-pass effect via carboxylesterase in the disposition of a propranolol ester derivative after intravenous administration.
Topics: Adrenergic beta-Antagonists; Algorithms; Animals; Antibodies, Blocking; Area Under Curve; Carboxylic Ester Hydrolases; Chromatography, High Pressure Liquid; Cytosol; Dogs; Electrophoresis, Polyacrylamide Gel; Enzyme Inhibitors; Hydrolysis; Injections, Intra-Arterial; Injections, Intravenous; Isoenzymes; Lung; Male; Microsomes; Nitrophenols; Propranolol; Rats; Rats, Wistar; Species Specificity; Stereoisomerism | 2003 |
Intestinal first-pass metabolism via carboxylesterase in rat jejunum and ileum.
Topics: Aminopeptidases; Anilides; Aniline Compounds; Animals; Biotransformation; Carboxylic Ester Hydrolases; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Hydrolysis; Ileum; Intestinal Absorption; Intestinal Mucosa; Isoenzymes; Jejunum; Male; Nitrophenols; Propranolol; Rats; Rats, Wistar; RNA, Messenger; Subcellular Fractions | 2007 |
Development of a novel system for estimating human intestinal absorption using Caco-2 cells in the absence of esterase activity.
Topics: Biological Transport; Caco-2 Cells; Carboxylesterase; Carboxylic Ester Hydrolases; Cell Membrane Permeability; Diffusion; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Enzyme Inhibitors; Esters; Humans; Intestinal Absorption; Nitrophenols; Prodrugs; Propranolol; Terfenadine | 2010 |
Evaluation of ligand-selector interaction from effective diffusion coefficient.
Topics: Adrenergic beta-Antagonists; Animals; Anticoagulants; Antitussive Agents; Cattle; Chromatography, High Pressure Liquid; Cyclodextrins; Diffusion; Ligands; Nitrophenols; Noscapine; Pharmaceutical Preparations; Photosensitizing Agents; Propranolol; Riboflavin; Salicylic Acid; Serum Albumin, Bovine; Warfarin | 2010 |